Vijay Modur - 25 Jan 2023 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc.

Reporting relationship: HEAD OF R&D
Issuer ticker: ELOX on Nasdaq
Reported as of: 25 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jan 2023, 15:02:53 UTC
Prior SEC filing: 03 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Sumit Aggarwal, Attorney-in-Fact for Vijay Modur

Key filing fact

Vijay Modur filed Form 4 for Eloxx Pharmaceuticals, Inc. on 27 Jan 2023.

Key facts

This page summarizes Vijay Modur's Form 4 filing for Eloxx Pharmaceuticals, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Jan 2023, 15:02.

Change

Previous filing in this sequence was filed on 03 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELOX transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +30,000
Change %
Price: $0.000000
Shares after: 30,000
Date: 25 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $4.27
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.

SEC remarks

On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share counts herein have been adjusted to reflect the reverse stock split.